FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:324-326 January 26, 2006 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

In November 2005, Woo Suk Hwang, the leader of a South Korean team conducting stem-cell research, touched off an international uproar when he admitted that he had used oocytes from junior scientists in his laboratory as well as from paid donors and that he had lied about the circumstances under which the oocytes had been obtained. Subsequent questions about fraud in the underlying science mushroomed into scandal. As of mid-January, the group's 2005 report about the derivation of patient-specific embryonic stem cells from human blastocysts created by somatic-cell nuclear transfer¹ was being retracted, as was its 2004 report in Science . . . [Full Text of this Article]

Source Information

Dr. Steinbrook is a national correspondent for the Journal.

This article has been cited by other articles:

• Kirejczyk, M. (2008). On Women, Egg Cells and Embryos: Gender in the Regulatory Debates on Embryonic Research in the Netherlands. European Journal of Women's Studies 15: 377-391 [Abstract]  
• Baylis, F, McLeod, C (2007). The stem cell debate continues: the buying and selling of eggs for research. J. Med. Ethics 33: 726-731 [Full Text]  
• Thomas, C. F. Jr., Vassallo, R., Castro, M. (2006). Against the ATS Statement on Human Embryonic Stem Cell Research.. Am. J. Respir. Crit. Care Med. 174: 357-357 [Full Text]